Meridian Bioscience, Inc. (VIVO) Reports Third Quarter And Nine Months Operating Results, Declares Regular Cash Dividend, And Reaffirms Fiscal 2014 Guidance
7/24/2014 11:51:29 AM
CINCINNATI--(BUSINESS WIRE)--Meridian Bioscience, Inc. (NASDAQ: VIVO) today:
•reported fiscal 2014 third quarter and first nine months net sales of $47.2 million and $142.1 million, respectively, flat and an increase of 2%, respectively, from the same periods of the prior fiscal year;
•reported third quarter operating income of $13.1 million, a decrease of 16% from the same period of the prior fiscal year;
Help employers find you! Check out all the jobs and post your resume.
comments powered by